alexa
Reach Us +44-7456026878
Improving the Quality of Life of Patients with Ureteral Malignant Obstruction | OMICS International
ISSN: 2165-7386
Journal of Palliative Care & Medicine
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business

Improving the Quality of Life of Patients with Ureteral Malignant Obstruction

Benoît Vogt1*, Arnaud Desgrippes1, Philippe Laplaige2, Jean-Michel Boulet2, Patrick Seys2 and François-Noël Desfemmes1

1Department of Urology, Polyclinic of Blois, 1 Rue Robert Debré, 41260 The Chaussée Saint-Victor, France

2Department of Oncology, Polyclinic of Blois, 1 Rue Robert Debré, 41260 The Chaussée Saint-Victor, France

*Corresponding Author:
Benoît Vogt
Department of Urology, Polyclinic of Blois, 1 Rue Robert Debré
41260 , The Chaussée Saint-Victor, France
Tel: 33663220844
E-mail: [email protected]

Received date: September 09, 2014; Accepted date: November 02, 2014; Published date: November 10, 2014

Citation: Vogt B, Desgrippes A, Laplaige P, Boulet JM, Seys P et al. (2014) Improving the Quality of Life of Patients with Ureteral Malignant Obstruction. J Palliat Care Med 4:196. doi:10.4172/2165-7386.1000196

Copyright: 2014 Vogt B, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Palliative Care & Medicine

Short Communication

In a patient with cancer, the ureter may be obstructed by tumor progression. The urologist implants a double-pigtail stent between the kidney and the bladder when an obstruction of the ureter is found.

International scientific medical studies estimate that 80% of patients complain of different symptoms [1]: incontinence, urinary frequency, urgency, dysuria, hematuria, pelvic and lumbar pain. The symptoms are largely due to bladder irritation caused by the stent and by reflux during bladder voiding (Figure 1).

palliative-care-medicine-double-pigtail-stents

Figure 1: Appearance of the double-pigtail stents on X ray and appearance of the inflamed ureteral meatus around the doublepigtail stent [2,3].

This treatment-induced suffering can cause an additional suffering to the canceroussymptoms. Thus, we developed a new ureteral stent.

In our view, the original stent is essential to bypass the obstacle but its presence is unnecessary below the stenosis when the ureter is healthy. Thus, the part of the stent in the bladder is of no use in such conditions and its presence may provoke unwanted secondary effects.

In our innovative stent, named pigtail suture stent, the lower part of the stent is replaced by a 0.3F suture thread. The ureteral meatus intubated by the thread shows no inflammation (Figure 2).

palliative-care-medicine-pigtail-suture-stent

Figure 2: Appearance of the pigtail suture stent on X ray. No ureteral inflammation is visible in contact with the suture thread.

Subsequently, we have improved tolerance stents [2,3] by creating a profiled tail but industrial manufacturers could further improve the profile of the tail that is currently manually sculpted (Figure 3).

palliative-care-medicine-manually-sculpted-tail

Figure 3: Appearance of the manually sculpted tail of the pigtail suture stent (endoscopic view).


We used these stents in more than 40 patients with cancer (Prostate, bladder, uterus, colon, and breast) or post-radiation stenosis. Stent symptoms are increased in case of prior pelvic irradiation. These diseases often force patients to keep the stent for the rest of their lives. This perspective associated with the stent symptoms, strongly affects the patient's feeling.

We wish to inform the oncology community that this new stent can fortunately improve the patient's quality of life when a malignant tumor causes ureter obstruction.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Article Usage

  • Total views: 11927
  • [From(publication date):
    November-2014 - Dec 09, 2019]
  • Breakdown by view type
  • HTML page views : 8151
  • PDF downloads : 3776
Top